Overview

• ACIP documents detail a new workgroup tasked with reassessing the childhood and adolescent schedule, including timing and order of shots, vaccine ingredients, monoclonal antibody use, and comparisons with other countries’ schedules.
• The Oct. 22–23 ACIP meeting was removed from the calendar without explanation, and HHS said future dates and agendas will be posted once finalized.
• Recent ACIP actions include delaying use of the combined MMRV vaccine, tabling a vote on hepatitis B timing for newborns, and shifting COVID-19 vaccine guidance toward individual decision-making.
• The roster and chair for the schedule workgroup have not been made public, leaving the process and timeline for any proposed changes unclear.
• HHS Secretary Robert F. Kennedy Jr. reshaped the committee with new appointees criticized by public health experts, and one member, Robert Malone, has indicated he will push for a substantially longer delay to the hepatitis B shot.